Wanqiang Sheng

Affiliations: 
2016- Harvard Medical School - Boston Children's Hospital 
Google:
"Wanqiang Sheng"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Qiu F, Jiang P, Zhang G, et al. (2024) Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nature Communications. 15: 4327
Zhang G, Jiang P, Tang W, et al. (2023) CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Molecular Cell
Liu Y, Debo B, Li M, et al. (2022) Author Correction: LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nature Communications. 13: 263
Liu Y, Debo B, Li M, et al. (2021) LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nature Communications. 12: 6831
Sheng W, Liu Y, Chakraborty D, et al. (2021) Simultaneous Inhibition of LSD1 and TGF-B Enables Eradication of Poorly Immunogenic Tumors with anti-PD-1 Treatment. Cancer Discovery
Sendinc E, Valle-Garcia D, Dhall A, et al. (2019) PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression. Molecular Cell
Sheng W, LaFleur MW, Nguyen TH, et al. (2018) LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. Cell
Xiang Y, Laurent B, Hsu CH, et al. (2017) Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature
Xiang Y, Laurent B, Hsu CH, et al. (2017) RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response. Nature
See more...